Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

698
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
698
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

73
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
73
Drug Dosage Regimen: Overview01:15

Drug Dosage Regimen: Overview

3.5K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.5K
Drug Concentration Versus Time Correlation01:15

Drug Concentration Versus Time Correlation

775
The plasma drug concentration-time curve is a crucial tool in pharmacokinetics, representing the drug's concentration in plasma at different time intervals post-administration. This curve illustrates the drug's journey from absorption into the systemic circulation, distribution to body tissues, and eventual elimination through excretion or biotransformation.
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
775
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

3.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
3.9K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Burden of cardiovascular diseases in breast cancer survivors: a 9-year retrospective cohort study based on regional medical data in Inner Mongolia China.

Cardio-oncology (London, England)·2026
Same author

Rapid Hemostasis and Antiadhesion Gauze Based on a Structured Hydrophobic Surface Engineered by an Inorganic LDH Array.

ACS applied materials & interfaces·2026
Same author

Evolving Diverse Red-team Language Models in Multi-round Multi-agent Games.

IEEE transactions on pattern analysis and machine intelligence·2026
Same author

Breastfeeding in infancy confers sex-specific, long-term protection against metabolic dysfunction-associated steatohepatitis and adverse liver outcomes.

Biology of sex differences·2026
Same author

Research on the generalization of a blood donor recruitment framework based on machine learning.

BMC medical informatics and decision making·2026
Same author

Instrumental variable estimation of a hazard ratio for treatment with a waiting time without specifying its dependence on unmeasured confounders: application to a procedural registry.

Lifetime data analysis·2026

相关实验视频

Updated: Jul 4, 2025

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.5K

改进了基于特征选择的堆叠组合学习,以准确预测华法林剂量.

Mingyuan Wang1,2, Yiyi Qian1, Yaodong Yang2

  • 1Department of Pharmacy, Fuwai Yunnan Cardiovascular Hospital, Kunming, China.

Frontiers in cardiovascular medicine
|February 5, 2024
PubMed
概括
此摘要是机器生成的。

一个改进的启发式堆叠集体学习模型准确预测华法林剂量,优于传统方法. 这种人工智能方法通过识别患者的关键因素,如高血压,来提高华法林的剂量.

关键词:
抗凝固剂是一种抗凝固剂.数据的相关性数据的相关性.监督机器学习是指监督机器学习.血栓形成的原因是血栓形成.在沃尔法林,

更多相关视频

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.2K
Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

727

相关实验视频

Last Updated: Jul 4, 2025

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.5K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.2K
Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

727

科学领域:

  • 人工智能的人工智能
  • 机器学习 机器学习
  • 药物基因组学 药物基因组学

背景情况:

  • 由于线性和非线性因素,华法林剂量预测是复杂的.
  • 传统的机器学习算法难以同时进行线性和非线性剂量预测.
  • 人工智能 (AI) 越来越多地应用于华法林剂量预测.

研究的目的:

  • 开发一个改进的堆叠组合学习模型,用于在中国患者中准确预测华法林剂量.
  • 通过利用临床华法林数据的特定特征来提高预测准确度.
  • 通过特征选择来确定影响华法林剂量的其他因素.

主要方法:

  • 收集了来自641名中国华法林患者的数据,包括人口统计,病史,基因型和联合药物.
  • 使用启发式堆叠集体学习方法进行预测.
  • 使用诸如理想剂量准确度,平均绝对误差,根平均平方误差和R平方等指标评估模型性能.
  • 采用特征选择方法来发现相关因素.

主要成果:

  • 启发式堆叠组合模型在理想剂量预测方面取得了更高的准确性 (73.44%) 与传统堆叠 (71.88%) 相比.
  • 新模型显示了较低的平均绝对误差 (0.11 mg/day对比0.13 mg/day) 和根平均平方误差 (0.18 mg/day对比0.20 mg/day).
  • 启发式堆叠模型产生了更高的R平方值 (0.87对0.82),表明更好的模型匹配.

结论:

  • 开发的启发式堆叠集体学习模型准确地预测了华法林剂量.
  • 高血压和手术前严重栓塞史被确定为影响华法林剂量的重要因素.
  • 这种基于人工智能的方法为优化华法林剂量管理提供了有价值的参考.